Carrie Adeline Cowardin

Title: Innovations by Carrie Adeline Cowardin

Introduction

Carrie Adeline Cowardin is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of medical research, particularly in understanding hospital-acquired pathogens. Her work has implications for improving patient outcomes and enhancing our understanding of infectious diseases.

Latest Patents

Carrie Adeline Cowardin holds 1 patent. Her patent addresses the virulence factors of a common hospital-acquired pathogen in the United States. This pathogen is known for its potentially fatal infections, with Toxins A and B being the major virulence factors. Additionally, a third toxin, known as transferase (CDT), has been identified. CDT is an ADP-ribosyltransferase that disrupts the actin cytoskeleton and is typically produced by hypervirulent strains. The research disclosed in her patent reveals that CDT enhances the virulence of specific strains in mice. It induces pathogenic host inflammation through a novel Toll-like Receptor 2 (TLR2) dependent pathway, which suppresses a protective eosinophilic response. The findings suggest that restoring TLR2 deficient eosinophils can provide protection against strains producing CDT.

Career Highlights

Carrie Adeline Cowardin is associated with the University of Virginia Patent Foundation. Her work has been instrumental in advancing our understanding of the mechanisms by which certain toxins affect host immune responses. This research is crucial for developing strategies to combat severe infections caused by hypervirulent strains.

Collaborations

Carrie has collaborated with William A. Petri, who is also a prominent figure in the field of infectious disease research. Their joint efforts have contributed to the advancement of knowledge regarding pathogenic mechanisms and potential therapeutic approaches.

Conclusion

Carrie Adeline Cowardin's innovative research and patent contributions significantly enhance our understanding of hospital-acquired pathogens and their virulence factors. Her work is vital for developing effective treatments and improving patient care in healthcare settings.